Wilmer Eye Institute/Johns Hopkins University

Baltimore, Maryland 21287-0005

2 studies enrolling now · 12 studies all time

What they study most

Age Related Macular Degeneration, Diabetic Macular Edema, Glaucoma, LCA (Leber Congenital Amaurosis), Neovascular Age-related Macular Degeneration, Non-infectious, Non-necrotizing Anterior Scleritis, RP (Retinitis Pigmentosa), Retinitis Pigmentosa, Stargardt Disease, Thyroid Eye Disease, Uveitis

Studies at this site

• A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS) — Recruiting now
• Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial — Recruiting now
• Oral N-acetylcysteine for Retinitis Pigmentosa — Running, not enrolling
• A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema — Running, not enrolling
• Celecoxib for Thyroid Eye Disease — Stopped early
• A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies — Completed
• The Detection of Glaucoma Using Pupillography — Completed
• Multicenter Uveitis Steroid Treatment (MUST) Trial — Completed
• Iontophoresis Delivery of Dexamethasone Phosphate for Non-infectious, Non-necrotizing Anterior Scleritis, Phase 1 Dose-varying Study — Completed
• Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01) — Completed
• The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot — Completed
• Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations — Completed